Recent Articles
Quality of Generic Drugs Manufactured Overseas Comes into Question
The passage of the Hatch-Waxman Act in 1984, which created a regulatory track for generic drugs, marked the beginning of the generic-drug boom in...
Who Foots the Surprise Bill?
As U.S. Senators prepare for a July vote on proposed legislation that would protect patients from surprise medical bills, three key players in the...
Current Issue
May 2019, Volume 5, Issue 6
This issue features a look at home-based care for hematologic disorders, strides in pediatric leukemia in El Salvador, and more.
